The 116th US Congress came into 2019 leaving many with the impression that drug pricing would largely be a focus of investigation, not successful legislation, from the new Democrat-controlled House. But a value-based contracting bill introduced by Sens. Bill Cassidy, R-LA, and Mark Warner, D-VA, might be an area that gains serious traction among lawmakers from both sides of the aisle, experts say.
According to draft legislation released Jan. 29, the Patient Affordability, Value and Efficiency Act would both provide a safe harbor...







